Waters has introduced the Xevo TQ Absolute XR IVD Mass Spectrometer, featuring up to five times greater sensitivity for clinical applications at the 2026 ADLM Annual Meeting.
A new NIH-funded study finds that elevated circular RNAs in blood may predict Alzheimer’s symptoms years in advance, outperforming current blood tests in forecasting disease progression.
The program connects researchers with certified laboratories offering single-molecule PCR testing, technical support, and bioinformatics expertise.
The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.
New analysis suggests that higher-sensitivity testing could lower annual spending by more than $3 billion by reducing misdiagnosis.
